Tejara Capital Ltd Increases Stock Holdings in Establishment Labs Holdings Inc. $ESTA

Tejara Capital Ltd boosted its position in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 31.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 102,494 shares of the company’s stock after acquiring an additional 24,386 shares during the period. Establishment Labs accounts for about 2.2% of Tejara Capital Ltd’s holdings, making the stock its 14th biggest position. Tejara Capital Ltd’s holdings in Establishment Labs were worth $4,201,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Osaic Holdings Inc. grew its position in shares of Establishment Labs by 900.0% during the 2nd quarter. Osaic Holdings Inc. now owns 2,000 shares of the company’s stock valued at $85,000 after purchasing an additional 1,800 shares in the last quarter. CWM LLC grew its position in Establishment Labs by 45.9% during the second quarter. CWM LLC now owns 2,182 shares of the company’s stock worth $93,000 after buying an additional 686 shares in the last quarter. Brian Low Financial Group LLC bought a new position in Establishment Labs in the 3rd quarter worth about $223,000. Patriot Financial Group Insurance Agency LLC raised its holdings in shares of Establishment Labs by 5.2% in the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 6,025 shares of the company’s stock valued at $257,000 after acquiring an additional 300 shares in the last quarter. Finally, ARS Investment Partners LLC purchased a new stake in shares of Establishment Labs in the 2nd quarter valued at about $278,000. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Establishment Labs Stock Performance

Establishment Labs stock opened at $68.15 on Friday. The firm has a fifty day simple moving average of $70.00 and a two-hundred day simple moving average of $53.88. The company has a quick ratio of 2.10, a current ratio of 3.33 and a debt-to-equity ratio of 15.06. Establishment Labs Holdings Inc. has a twelve month low of $26.56 and a twelve month high of $78.24. The company has a market capitalization of $1.98 billion, a PE ratio of -24.00 and a beta of 0.92.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings data on Wednesday, November 5th. The company reported ($0.38) EPS for the quarter, topping the consensus estimate of ($0.54) by $0.16. Establishment Labs had a negative return on equity of 235.45% and a negative net margin of 43.45%.The firm had revenue of $53.78 million for the quarter, compared to the consensus estimate of $52.28 million. During the same quarter in the previous year, the business earned ($0.59) earnings per share. The company’s quarterly revenue was up 33.8% on a year-over-year basis. Research analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Wall Street Analysts Forecast Growth

ESTA has been the subject of several recent analyst reports. BTIG Research boosted their price objective on Establishment Labs from $81.00 to $86.00 and gave the stock a “buy” rating in a report on Wednesday, December 31st. Needham & Company LLC reissued a “buy” rating and issued a $84.00 price target on shares of Establishment Labs in a research note on Monday, January 12th. Canaccord Genuity Group increased their price target on shares of Establishment Labs from $72.00 to $85.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Mizuho lifted their price objective on shares of Establishment Labs from $85.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, December 17th. Finally, JPMorgan Chase & Co. upped their target price on shares of Establishment Labs from $71.00 to $80.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. Six equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $78.86.

Establishment Labs Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.